| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 254 | No Change | 0 | 0 % | $1,052 | $1,013 | $-38 | -3.62 % | $0 | | | | | | News Article | History of Amvescap Plc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -29,192 | -100 % | | | | -3.62 % | $4,379 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 10,867 | Added More | 22 | 0.20 % | $44,989 | $43,359 | $-1,630 | -3.62 % | $-3 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Algert Coldiron Investors Llc | Institution | 21,710 | Sold Some | -2,360 | -9.80 % | $90,531 | $86,623 | $-3,908 | -4.31 % | $425 | | | | | | News Article | History of Algert Coldiron Investors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 21,651 | No Change | 0 | 0 % | $90,285 | $86,387 | $-3,897 | -4.31 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 15,474 | Added More | 5,198 | 50.58 % | $64,527 | $61,741 | $-2,785 | -4.31 % | $-936 | | | | | | News Article | History of Citadel L P Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 810 | No Change | 0 | 0 % | $3,378 | $3,232 | $-146 | -4.31 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 107,800 | Added More | 900 | 0.84 % | $449,526 | $430,122 | $-19,404 | -4.31 % | $-162 | | | | | | News Article | History of Fmr Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Grt Capital Partners Llc | Institution | 37,580 | No Change | 0 | 0 % | $156,709 | $149,944 | $-6,764 | -4.31 % | $0 | | | | | | News Article | History of Grt Capital Partners Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 13,860 | Added More | 2,410 | 21.04 % | $57,796 | $55,301 | $-2,495 | -4.31 % | $-434 | | | | | | News Article | History of Ing Groep Nv Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | | Sold All | -1,943 | -100 % | | | | -4.31 % | $350 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | | Sold All | -71,563 | -100 % | | | | -4.31 % | $12,881 | | | | | | News Article | History of Millennium Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 2,162,431 | Added More | 34,175 | 1.60 % | $9,017,337 | $8,628,100 | $-389,238 | -4.31 % | $-6,152 | | | | | | News Article | History of Morgan Stanley Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 343,268 | Added More | 28,893 | 9.19 % | $1,431,428 | $1,369,639 | $-61,788 | -4.31 % | $-5,201 | | | | | | News Article | History of Northern Trust Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 900 | Sold Some | -368,379 | -99.75 % | $3,753 | $3,591 | $-162 | -4.31 % | $66,308 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Quantlab Capital Management Ltd | Institution | 20,000 | New Holding | 20,000 | 100 % | $83,400 | $79,800 | $-3,600 | -4.31 % | $-3,600 | | | | | | News Article | History of Quantlab Capital Management Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 200,503 | Added More | 51,912 | 34.93 % | $836,098 | $800,007 | $-36,091 | -4.31 % | $-9,344 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 18,173 | Sold Some | -7,227 | -28.45 % | $75,781 | $72,510 | $-3,271 | -4.31 % | $1,301 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 180 | No Change | 0 | 0 % | $751 | $718 | $-32 | -4.31 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 1,882,496 | Sold Some | -140,830 | -6.96 % | $7,850,008 | $7,511,159 | $-338,849 | -4.31 % | $25,349 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | | Sold All | -12,800 | -100 % | | | | 5.83 % | $-2,816 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 78,923 | Sold Some | -80,936 | -50.62 % | $297,540 | $314,903 | $17,363 | 5.83 % | $-17,806 | | | | | | News Article | History of Axa Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 41,003 | Sold Some | -37,391 | -47.69 % | $154,581 | $163,602 | $9,021 | 5.83 % | $-8,226 | | | | | | News Article | History of Barclays Plc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 350 | No Change | 0 | 0 % | $1,320 | $1,397 | $77 | 5.83 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 76,200 | No Change | 0 | 0 % | $287,274 | $304,038 | $16,764 | 5.83 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Falcon Investment Management Llc | Institution | | Sold All | -58,400 | -100 % | | | | 5.83 % | $-12,848 | | | | | | News Article | History of Falcon Investment Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 109 | Sold Some | -20,491 | -99.47 % | $411 | $435 | $24 | 5.83 % | $-4,508 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 106,776 | Added More | 24,204 | 29.31 % | $402,546 | $426,036 | $23,491 | 5.83 % | $5,325 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 599,376 | Sold Some | -122,160 | -16.93 % | $2,259,648 | $2,391,510 | $131,863 | 5.83 % | $-26,875 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | 124,900 | Sold Some | -8,600 | -6.44 % | $470,873 | $498,351 | $27,478 | 5.83 % | $-1,892 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 23,500 | Sold Some | -23,200 | -49.67 % | $88,595 | $93,765 | $5,170 | 5.83 % | $-5,104 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 42,139 | New Holding | 42,139 | 100 % | $158,864 | $168,135 | $9,271 | 5.83 % | $9,271 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 26,700 | Added More | 8,900 | 50.00 % | $100,659 | $106,533 | $5,874 | 5.83 % | $1,958 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 4,734 | Added More | 4,434 | 1478.00 % | $17,847 | $18,889 | $1,041 | 5.83 % | $975 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 117,989 | Added More | 4,186 | 3.67 % | $444,819 | $470,776 | $25,958 | 5.83 % | $921 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 17,134 | Added More | 10,013 | 140.61 % | $64,595 | $68,365 | $3,769 | 5.83 % | $2,203 | | | | | | News Article | History of Sei Trust Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Toronto Dominion Bank | Institution | | Sold All | -11,576 | -100 % | | | | 5.83 % | $-2,547 | | | | | | News Article | History of Toronto Dominion Bank Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tudor Investment Corp Et Al | Institution | 2,342,388 | No Change | 0 | 0 % | $8,830,803 | $9,346,128 | $515,325 | 5.83 % | $0 | | | | | | News Article | History of Tudor Investment Corp Et Al Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 1,172,450 | Added More | 38,050 | 3.35 % | $4,420,137 | $4,678,076 | $257,939 | 5.83 % | $8,371 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,798,206 | Added More | 36,142 | 2.05 % | $6,383,631 | $7,174,842 | $791,211 | 12.39 % | $15,902 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 19,201 | New Holding | 19,201 | 100 % | $68,164 | $76,612 | $8,448 | 12.39 % | $8,448 | | | | | | News Article | History of Credit Suisse Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 40,728 | No Change | 0 | 0 % | $144,584 | $162,505 | $17,920 | 12.39 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 13,760 | Added More | 2,310 | 20.17 % | $48,848 | $54,902 | $6,054 | 12.39 % | $1,016 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 14,415 | No Change | 0 | 0 % | $51,173 | $57,516 | $6,343 | 12.39 % | $0 | | | | | | News Article | History of Kbc Group Nv Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kinetics Asset Management Inc | Institution | | Sold All | -28,200 | -100 % | | | | 12.39 % | $-12,408 | | | | | | News Article | History of Kinetics Asset Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Knott David M | Institution | 512,861 | Sold Some | -1,100 | -0.21 % | $1,820,657 | $2,046,315 | $225,659 | 12.39 % | $-484 | | | | | | News Article | History of Knott David M Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | | Sold All | -4,550 | -100 % | | | | 12.39 % | $-2,002 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 29,185 | Added More | 1,875 | 6.86 % | $103,607 | $116,448 | $12,841 | 12.39 % | $825 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 233,400 | Added More | 85,000 | 57.27 % | $828,570 | $931,266 | $102,696 | 12.39 % | $37,400 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 935 | Sold Some | -16,649 | -94.68 % | $3,319 | $3,731 | $411 | 12.39 % | $-7,326 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 1,198 | Sold Some | -109,105 | -98.91 % | $4,253 | $4,780 | $527 | 12.39 % | $-48,006 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | | Sold All | -361,673 | -100 % | | | | 12.39 % | $-159,136 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 37,222 | Added More | 3,449 | 10.21 % | $132,138 | $148,516 | $16,378 | 12.39 % | $1,518 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 65,400 | Added More | 2,000 | 3.15 % | $232,170 | $260,946 | $28,776 | 12.39 % | $880 | | | | | | News Article | History of United Services Automobile Association Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 75,900 | No Change | 0 | 0 % | $269,445 | $302,841 | $33,396 | 12.39 % | $0 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | | Sold All | -51,945 | -100 % | | | | 10.52 % | $-19,739 | | | | | | News Article | History of Citigroup Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Duncker Streett And Co Inc | Institution | 17,000 | New Holding | 17,000 | 100 % | $61,370 | $67,830 | $6,460 | 10.52 % | $6,460 | | | | | | News Article | History of Duncker Streett And Co Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 22,253 | Added More | 146 | 0.66 % | $80,333 | $88,789 | $8,456 | 10.52 % | $55 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ig Investment Management Ltd | Institution | 128,272 | No Change | 0 | 0 % | $463,062 | $511,805 | $48,743 | 10.52 % | $0 | | | | | | News Article | History of Ig Investment Management Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 60,706 | Added More | 2,965 | 5.13 % | $219,149 | $242,217 | $23,068 | 10.52 % | $1,127 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 3,694,465 | Sold Some | -109,813 | -2.88 % | $13,337,019 | $14,740,915 | $1,403,897 | 10.52 % | $-41,729 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 8,408 | Added More | 7,408 | 740.80 % | $30,353 | $33,548 | $3,195 | 10.52 % | $2,815 | | | | | | News Article | History of Ubs Ag Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 5,747,550 | Added More | 1,156,338 | 25.18 % | $21,783,215 | $22,932,725 | $1,149,510 | 5.27 % | $231,268 | | | | | | News Article | History of Federated Investors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 150,130 | Sold Some | -136,890 | -47.69 % | $568,993 | $599,019 | $30,026 | 5.27 % | $-27,378 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 21,669 | No Change | 0 | 0 % | $83,426 | $86,459 | $3,034 | 3.63 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 50 | Sold Some | -2,884 | -98.29 % | $193 | $200 | $7 | 3.63 % | $-404 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 198,375 | Sold Some | -64,673 | -24.58 % | $763,744 | $791,516 | $27,773 | 3.63 % | $-9,054 | | | | | | News Article | History of Tcw Group Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 27,136 | No Change | 0 | 0 % | $104,474 | $108,273 | $3,799 | 3.63 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 181,833 | Sold Some | -7,300 | -3.85 % | $700,057 | $725,514 | $25,457 | 3.63 % | $-1,022 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -10,411 | -100 % | | | | 2.83 % | $-1,145 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | | Sold All | -600 | -100 % | | | | 4.72 % | $-108 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 54,300 | New Holding | 54,300 | 100 % | $214,485 | $216,657 | $2,172 | 1.01 % | $2,172 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 102,400 | No Change | 0 | 0 % | $404,480 | $408,576 | $4,096 | 1.01 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 20,245 | Added More | 4,295 | 26.92 % | $84,827 | $80,778 | $-4,049 | -4.77 % | $-859 | | | | | | News Article | History of Oxford Asset Management Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,275 | No Compare | | | $5,342 | $5,087 | $-255 | -4.77 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 656,507 | Sold Some | -500 | -0.07 % | $2,960,847 | $2,619,463 | $-341,384 | -11.52 % | $260 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | 2,100 | New Holding | 2,100 | 100 % | $9,471 | $8,379 | $-1,092 | -11.52 % | $-1,092 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 21,651 | New Holding | 21,651 | 100 % | $97,646 | $86,387 | $-11,259 | -11.52 % | $-11,259 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Bailard Biehl And Kaiser Inc | Institution | 157,000 | Added More | 7,000 | 4.66 % | $681,380 | $626,430 | $-54,950 | -8.06 % | $-2,450 | | | | | | News Article | History of Bailard Biehl And Kaiser Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 12,800 | Added More | 2,827 | 28.34 % | $55,552 | $51,072 | $-4,480 | -8.06 % | $-989 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 9,631 | No Change | 0 | 0 % | $44,784 | $38,428 | $-6,356 | -14.19 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -9,020 | -100 % | | | | -14.19 % | $5,953 | | | | | | News Article | History of Blackrock Inc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 98,027 | Added More | 23,730 | 31.93 % | $455,826 | $391,128 | $-64,698 | -14.19 % | $-15,662 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 129,223 | Sold Some | -73,426 | -36.23 % | $612,517 | $515,600 | $-96,917 | -15.82 % | $55,070 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 51,849 | Added More | 9,774 | 23.22 % | $245,764 | $206,878 | $-38,887 | -15.82 % | $-7,331 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 48,900 | No Change | 0 | 0 % | $244,500 | $195,111 | $-49,389 | -20.20 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Stoneridge Investment Partners Llc | Institution | | Sold All | -10,500 | -100 % | | | | -20.20 % | $10,605 | | | | | | News Article | History of Stoneridge Investment Partners Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 11,600 | No Change | 0 | 0 % | $58,116 | $46,284 | $-11,832 | -20.35 % | $0 | | | | | | News Article | History of Strs Ohio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | | Sold All | -10,500 | -100 % | | | | -18.57 % | $9,555 | | | | | | News Article | History of Harris Financial Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 32,624 | No Change | 0 | 0 % | $159,858 | $130,170 | $-29,688 | -18.57 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 44,283 | Added More | 250 | 0.56 % | $212,116 | $176,689 | $-35,426 | -16.70 % | $-200 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 9,000 | Added More | 4,500 | 100.00 % | $46,620 | $35,910 | $-10,710 | -22.97 % | $-5,355 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 63,300 | New Holding | 63,300 | 100 % | $311,436 | $252,567 | $-58,869 | -18.90 % | $-58,869 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 49,146 | No Change | 0 | 0 % | $267,846 | $196,093 | $-71,753 | -26.78 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 18,600 | No Change | 0 | 0 % | $101,370 | $74,214 | $-27,156 | -26.78 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 500 | No Change | 0 | 0 % | $2,725 | $1,995 | $-730 | -26.78 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Global Health Fund | Health/Biotech | 476 | Sold Some | -19 | -3.83 % | $2,594 | $1,899 | $-695 | -26.78 % | $28 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Global Health Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 303 | No Change | 0 | 0 % | $1,651 | $1,209 | $-442 | -26.78 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -2,750 | -100 % | | | | -28.49 % | $4,373 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -5,000 | -100 % | | | | -28.49 % | $7,950 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 3,886 | No Change | 0 | 0 % | $21,684 | $15,505 | $-6,179 | -28.49 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 508 | New Holding | 508 | 100 % | $2,835 | $2,027 | $-808 | -28.49 % | $-808 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -8,275 | -100 % | | | | -27.45 % | $12,495 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 14,415 | Sold Some | -8,212 | -36.29 % | $79,283 | $57,516 | $-21,767 | -27.45 % | $12,400 | | | | | | News Article | History of Kbc Group Nv Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 350 | No Change | 0 | 0 % | $1,894 | $1,397 | $-497 | -26.24 % | $0 | | | | | | News Article | History of Credit Agricole S A Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 570 | New Holding | 570 | 100 % | $3,141 | $2,274 | $-866 | -27.58 % | $-866 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -50 | -100 % | | | | -25.14 % | $67 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,762,064 | Added More | 194,100 | 12.37 % | $9,268,457 | $7,030,635 | $-2,237,821 | -24.14 % | $-246,507 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 714 | Sold Some | -144 | -16.78 % | $3,791 | $2,849 | $-942 | -24.85 % | $190 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 17,054 | Sold Some | -7,571 | -30.74 % | $90,557 | $68,045 | $-22,511 | -24.85 % | $9,994 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | 169,336 | Added More | 29,136 | 20.78 % | $914,414 | $675,651 | $-238,764 | -26.11 % | $-41,082 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -19,600 | -100 % | | | | -26.11 % | $27,636 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 45,600 | Added More | 31,000 | 212.32 % | $246,240 | $181,944 | $-64,296 | -26.11 % | $-43,710 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 4,780 | New Holding | 4,780 | 100 % | $25,812 | $19,072 | $-6,740 | -26.11 % | $-6,740 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 71,079 | Added More | 7,160 | 11.20 % | $383,827 | $283,605 | $-100,221 | -26.11 % | $-10,096 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc - Hartford Global Health Hls Fund | Health/Biotech | 244 | New Holding | 244 | 100 % | $1,318 | $974 | $-344 | -26.11 % | $-344 | | | | | | News Article | History of Hartford Series Fund Inc - Hartford Global Health Hls Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -4 | -100 % | | | | -26.11 % | $6 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | | Sold All | -28 | -100 % | | | | -26.11 % | $39 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 4,690 | Sold Some | -1,910 | -28.93 % | $25,326 | $18,713 | $-6,613 | -26.11 % | $2,693 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 4,000 | Added More | 320 | 8.69 % | $21,080 | $15,960 | $-5,120 | -24.28 % | $-410 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 330 | No Compare | | | $1,739 | $1,317 | $-422 | -24.28 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Value Index Portfolio | No Data | 134 | No Compare | | | $706 | $535 | $-172 | -24.28 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Value Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 14,802 | New Holding | 14,802 | 100 % | $78,007 | $59,060 | $-18,947 | -24.28 % | $-18,947 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -4,534 | -100 % | | | | -24.28 % | $5,804 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR | Algert Coldiron Investors Llc | Institution | 24,070 | New Holding | 24,070 | 100 % | $125,886 | $96,039 | $-29,847 | -23.70 % | $-29,847 | | | | | | News Article | History of Algert Coldiron Investors Llc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 254 | Sold Some | -254 | -50.00 % | $1,328 | $1,013 | $-315 | -23.70 % | $315 | | | | | | News Article | History of Amvescap Plc Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 106,900 | No Change | 0 | 0 % | $559,087 | $426,531 | $-132,556 | -23.70 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Progenics Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 109,589 | Added More | 30,803 | 39.09 % | $573,150 | $437,260 | $-135,890 | -23.70 % | $-38,196 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -520 | -100 % | | | | -24.28 % | $666 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 300 | No Change | 0 | 0 % | $1,581 | $1,197 | $-384 | -24.28 % | $0 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -63,300 | -100 % | | | | -24.28 % | $81,024 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 303,079 | Sold Some | -14,632 | -4.60 % | $1,618,442 | $1,209,285 | $-409,157 | -25.28 % | $19,753 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 144,875 | Sold Some | -35,633 | -19.74 % | $773,633 | $578,051 | $-195,581 | -25.28 % | $48,105 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 321,777 | Sold Some | -7,472 | -2.26 % | $1,718,289 | $1,283,890 | $-434,399 | -25.28 % | $10,087 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Value Index Fund | Multi-Cap Value | 54,258 | New Holding | 54,258 | 100 % | $289,738 | $216,489 | $-73,248 | -25.28 % | $-73,248 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Value Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 1,567 | Sold Some | -168 | -9.68 % | $8,368 | $6,252 | $-2,115 | -25.28 % | $227 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 6,999 | Added More | 420 | 6.38 % | $37,375 | $27,926 | $-9,449 | -25.28 % | $-567 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | 435 | New Holding | 435 | 100 % | $2,323 | $1,736 | $-587 | -25.28 % | $-587 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 42,931 | Added More | 12,164 | 39.53 % | $229,252 | $171,295 | $-57,957 | -25.28 % | $-16,421 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Small Cap Growth Stock Fund | Small-Cap Growth | | Sold All | -201,634 | -100 % | | | | -25.28 % | $272,206 | | | | | | News Article | History of Sti Classic Funds - Small Cap Growth Stock Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 10,845 | Added More | 10,745 | 10745.00 % | $57,912 | $43,272 | $-14,641 | -25.28 % | $-14,506 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 18,036 | Added More | 11,401 | 171.83 % | $100,100 | $71,964 | $-28,136 | -28.10 % | $-17,786 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -9,465 | -100 % | | | | -28.10 % | $14,765 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 134,902 | New Holding | 134,902 | 100 % | $748,706 | $538,259 | $-210,447 | -28.10 % | $-210,447 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 234,149 | New Holding | 234,149 | 100 % | $1,299,527 | $934,255 | $-365,272 | -28.10 % | $-365,272 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 304,981 | New Holding | 304,981 | 100 % | $1,692,645 | $1,216,874 | $-475,770 | -28.10 % | $-475,770 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 8,236 | No Change | 0 | 0 % | $45,710 | $32,862 | $-12,848 | -28.10 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 17,436 | Added More | 9,200 | 111.70 % | $96,770 | $69,570 | $-27,200 | -28.10 % | $-14,352 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio | No Data | | Sold All | -40,100 | -100 % | | | | -26.51 % | $57,744 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 23,189 | New Holding | 23,189 | 100 % | $123,829 | $92,524 | $-31,305 | -25.28 % | $-31,305 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-21 | 2009-06-30 | N-CSR | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 98,990 | New Holding | 98,990 | 100 % | $544,445 | $394,970 | $-149,475 | -27.45 % | $-149,475 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-21 | 2009-03-31 | 13F-HR/A | First Mercantile Trust Co | Institution | | Sold All | -118,565 | -100 % | | | | -27.45 % | $179,033 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Progenics Pharmaceuticals Inc |
| 2009-08-21 | 2008-12-31 | 13F-HR/A | First Mercantile Trust Co | Institution | 118,565 | New Holding | 118,565 | 100 % | $652,108 | $473,074 | $-179,033 | -27.45 % | $-179,033 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Progenics Pharmaceuticals Inc |
RSS feed for PGNX